Biweekly vs Triweekly low dose intravenous ketamine acute series for severe major depression: A case report
Background: One third of the patients with Major Depression Disorder (MDD) fail to respond to conventional antidepressant treatments - treatment resistant depression (TRD). Low-dose IV ketamine (LDIVK) treatment has become a promising solution for these patients. However, infusion regimens for LDIVK...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-12-01
|
Series: | Journal of Affective Disorders Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666915323001580 |